Osimertinib-induced Keratitis and Secondary Toxic Epidermal Necrotic Drug Eruption- A Case Report and Literature Review

BACKGROUND: Osimertinib is a third-generation Tyrosine Kinase inhibitor, mainly used in non-small cell lung cancer with EGFR mutation. Its efficacy and safety have been confirmed by clinical practice. Toxic epidermolysis necrotizing disease (TEN) is a severe drug eruption that is rare in clinics and...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yunhua, Li, Yong, Luo, Jie, Tang, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2023
Materias:
Drug Design, Discovery and Therapy, Drug Design & Discovery, Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680087/
https://www.ncbi.nlm.nih.gov/pubmed/37254553
http://dx.doi.org/10.2174/1574886318666230529123200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680087/
https://www.ncbi.nlm.nih.gov/pubmed/37254553
http://dx.doi.org/10.2174/1574886318666230529123200

Ejemplares similares